Abstract Details

Title Outcome after Two Years of Enzyme Replacement Therapy (ERT) in 29 Patients with Late-Onset Type II Glycogenosis (GSDII)

Topic Neurogenetics and Gene Therapy

Presentation(s) (-)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Sabrina Ravaglia (Institute of Neurology C Mondino)	No disclosure on file
Luca Marinelli	Luca Marinelli has received personal compensation for serving as an employee of General Electric.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��